Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations.

被引：2
|
作者：
Mhanna, Laurent
Milia, Julie
Lusque, Amellie
Couraud, Sebastien
Mascaux, Celine
Veillon, Remi
Frueh, Martin
Moro-Sibilot, Denis
Lattuca-Truc, Mickael
Tomasini, Pascale
Barlesi, Fabrice
Drilon, Alexander E.
Gautschi, Oliver
Mazieres, Julien
机构：
[1] Univ Hosp Toulouse Larrey, Toulouse, France
[2] Ctr Hosp Univ Toulouse, Hop Larrey, Toulouse, France
[3] Inst Univ Canc Toulouse Oncopole Cellule Biostat, Bur Essais Clin, Toulouse, France
[4] Lyon Sud Hosp, Acute Resp Med & Thorac Oncol Dept, Pierre Benite, France
[5] Lyon Univ, Canc Inst, Pierre Benite, France
[6] Aix Marseille Univ, Aix En Provence, France
[7] Assistance Publ Hop Marseille, Marseille, France
[8] Hop Haut Leveque, Pessac, France
[9] Cantonal Hosp St Gallen, St Gallen, Switzerland
[10] CHU Grenoble, IFCT, Grenoble, France
[11] Univ Hosp Grenoble, Grenoble, France
[12] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[13] Aix Marseille Univ, Assistance Publ Hop Marseille, Marseille, France
[14] Mem Sloan Kettering Canc Ctr, New York, NY USA
[15] Cantonal Hosp Lucerne, Luzern, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 05期
关键词：
D O I：
10.1200/JCO.2018.36.5_suppl.172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
172
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Immune-Checkpoint Inhibitors: Biomarkers to Predict Response to Immunotherapy in Non-small Cell Lung Cancer Patients
    Tostes, Senhorita Katiane
    Sorroche, Bruna Pereira
    Rodrigues, Nathalia de Carvalho
    Dias, Tauana Christina
    Lima, Joyce Alessandra
    Ferreira da Silva, Flavio Augusto
    Martins de Marchi, Pedro Rafael
    Pinheiro, Celine Marques
    Leal, Leticia Ferro
    Rebolho Batista Arantes, Lidia Maria
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S26 - S26
  • [22] Efficacy and Safety of Immune Checkpoint Inhibitors (ICI) in Resectable Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis
    Xiao, T.
    Verma, S.
    Boldt, G.
    Rajeh, A.
    Breadner, D.
    Raphael, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : E6 - E6
  • [23] Exploring the immune-checkpoint inhibitors' efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease
    Passiglia, Francesco
    Cetoretta, Valeria
    De Filippis, Marco
    Napoli, Valerio
    Novello, Silvia
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2876 - 2889
  • [24] Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
    Wang, Shuai
    Hao, Jiatao
    Wang, Hao
    Fang, Yong
    Tan, Lijie
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [25] Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI)
    Hendriks, L.
    Henon, C.
    Auclin, E.
    Mezquita, L.
    Ferrara, R.
    Valette, C. Audigier
    Mazieres, J.
    Lefebvre, C.
    Le Moulec, S.
    Duchemann, B.
    Le Pechoux, C.
    Botticella, A.
    Ammari, S.
    Gazzah, A.
    Caramella, C.
    Adam, J.
    Planchard, D.
    De Ruysscher, D.
    Dingemans, A-M. C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] Efficacy and safety of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC): a systematic literature review
    Wagner, Gernot
    Stollenwerk, Hannah Karolina
    Klerings, Irma
    Pecherstorfer, Martin
    Gartlehner, Gerald
    Singer, Josef
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [27] Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors
    Skribek, Marcus
    Rounis, Konstantinos
    Afshar, Soren
    Grundberg, Oscar
    Friesland, Signe
    Tsakonas, Georgios
    Ekman, Simon
    De Petris, Luigi
    EUROPEAN JOURNAL OF CANCER, 2021, 145 : 245 - 254
  • [28] Is There Any Role of Residential Radon in Non-Small Cell Lung Cancer (NSCLC) Patients Harboring Molecular Alterations?
    Mezquita, Laura
    Benito, Amparo
    Eugenia Olmedo, Maria
    Reguera, Pablo
    Madariaga, Ainhoa
    Villamayor, Maria
    Patricia Cortez, Silvia
    Gorospe, Luis
    Santon, Almudena
    Mayoralas, Sagrario
    Hernanz, Raul
    Cabanero, Alberto
    Carrato, Alfredo
    Garrido, Pilar
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S450 - S450
  • [29] Vimentin expression correlates with immune-checkpoint inhibitor efficacy in non-small cell lung cancer
    Nakahama, Kenji
    Izumi, Motohiro
    Yoshimoto, Naoki
    Fukui, Mitsuru
    Sugimoto, Akira
    Nagamine, Hiroaki
    Ogawa, Koichi
    Sawa, Kenji
    Tani, Yoko
    Kaneda, Hiroyasu
    Mitsuoka, Shigeki
    Watanabe, Tetsuya
    Asai, Kazuhisa
    Kawaguchi, Tomoya
    CANCER, 2023, 129 (15) : 2297 - 2307
  • [30] Impact of Intercurrent Introduction of Steroids on Clinical Outcomes in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients under Immune-Checkpoint Inhibitors (ICI)
    De Giglio, Andrea
    Mezquita, Laura
    Auclin, Edouard
    Blanc-Durand, Felix
    Riudavets, Mariona
    Caramella, Caroline
    Martinez, Gala
    Benitez, Jose Carlos
    Martin-Romano, Patricia
    El-Amarti, Lamiae
    Hendriks, Lizza
    Ferrara, Roberto
    Naltet, Charles
    Lavaud, Pernelle
    Gazzah, Anas
    Adam, Julien
    Planchard, David
    Chaput, Nathalie
    Besse, Benjamin
    CANCERS, 2020, 12 (10) : 1 - 11
12345